Parkinson’s Foundation researchers and other scientists worldwide make continual advances in understanding Parkinson’s disease (PD) with revolutionary research. We monitor it all in our effort to improving care and advance research toward a cure. Browse our collection here:
A new laboratory study finds that salicylic acid, the substance that gives aspirin its medicinal effects, blocks a molecular process that leads to brain cell death in Parkinson’s disease (PD) and other neurodegenerative diseases. The results appear in the November 25 edition of PLOS ONE.